Dr. David M. Chambers, M.D.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- Indiana University School of Medicine (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 241
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: Indiana University School of Medicine
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
LA license 309288 · NC license 2017-00207 -
Critical Care Medicine (Internal Medicine) Physician
LA license 309288 · NC license 2017-00207
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Fmol Health St Francis Monroe, LA
- Ochsner Lsu Health Shreveport Shreveport, LA
- Ochsner Lsu Health Shreveport-St Mary Medical Cent Shreveport, LA
- Ochsner Lsu Health Monroe Monroe, LA
- Natchitoches Regional Medical Center Natchitoches, LA
Medical groups
- Lsu Health Sciences Center Shreveport Faculty Group Practice (571 clinicians)
- Nrmc Physician Ipa Inc (30 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 241
- Services billed
- 453
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 66 | 21 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 40 | 20 |
| Established patient office or other outpatient visit, 20-29 minutes | 36 | 34 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 22 | 13 |
| Established patient office or other outpatient visit, 30-39 minutes | 21 | 19 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 18 | 17 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 16 | 16 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 14 | 13 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 12 | 11 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Shreveport, LA | 90 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Shreveport, LA | 77 |
| Prednisone Other prescribers in Shreveport, LA | 51 |
| Azithromycin Other prescribers in Shreveport, LA | 38 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Shreveport, LA | 32 |
| Advair Hfa (fluticasone propion/salmeterol) Other prescribers in Shreveport, LA | 31 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Shreveport, LA | 25 |
| Ventolin Hfa (albuterol sulfate) Other prescribers in Shreveport, LA | 22 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Shreveport, LA | 22 |
| Montelukast Sodium Other prescribers in Shreveport, LA | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 26 companies reported 116 payments worth $2,386 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $512 |
|---|---|
| GlaxoSmithKline, LLC. | $411 |
| Actelion Pharmaceuticals US, Inc. | $232 |
| Genzyme Corporation | $227 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $140 |
| Merck Sharp & Dohme LLC | $139 |
| Regeneron Healthcare Solutions, Inc. | $104 |
| Insmed, Inc. | $99.70 |
| Food and Beverage | $2,386 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.